Arrowhead Pharmaceuticals, Inc. (ARWR): Free Cash Flow
-$283.94M
Year ended 2026-09-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2026-09-30 | -$283.94M | n/m | 2026-11-12, From 2025-10-01 |
| 2025-09-30 | $156.89M | n/m | 2026-11-12, From 2024-10-01 |
| 2024-09-30 | -$604.32M | n/m | 2026-11-12, From 2023-10-01 |
| 2023-09-30 | -$330.63M | n/m | 2025-11-25, From 2022-10-01 |
| 2022-09-30 | -$188.91M | n/m | 2024-11-26, From 2021-10-01 |
| 2021-09-30 | $147.75M | n/m | 2023-11-29, From 2020-10-01 |
| 2020-09-30 | -$107.75M | n/m | 2022-11-28, From 2019-10-01 |
| 2019-09-30 | $161.03M | n/m | 2021-11-22, From 2018-10-01 |
| 2018-09-30 | -$48.64M | n/m | 2020-11-23, From 2017-10-01 |
| 2017-09-30 | -$31.86M | n/m | 2019-11-25, From 2016-10-01 |
| 2016-09-30 | -$68.29M | n/m | 2018-12-11, From 2015-10-01 |
| 2015-09-30 | -$67.68M | n/m | 2017-12-12, From 2014-10-01 |
| 2014-09-30 | -$37.13M | n/m | 2016-12-14, From 2013-10-01 |
| 2013-09-30 | -$19.33M | n/m | 2015-12-14, From 2012-10-01 |
| 2012-09-30 | -$15.82M | n/m | 2014-11-25, From 2011-10-01 |
| 2011-09-30 | -$7.67M | n/a | 2012-12-28, From 2010-10-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2026-09-30 | -$283.94M | n/m |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | -$158.89M | n/m |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $28.84M | +101.3% |
| Innoviva, Inc. (INVA) | 2025-12-31 | $195.80M | +3.9% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | -$43.98M | n/m |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | -$447.01M | n/m |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $54.87M | +488.0% |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | -$561.10M | n/m |
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | -$6.31M | n/m |
Compare ARWR, ZLAB, NATR, INVA side by side · Screen every company in Pharmaceutical Preparations ↗